Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis

References

• Han B, Hur K, Ohn J, et al. Hydroa vacciniforme-like lymphoproliferative disorder in Korea. Sci Rep. 2020;10(1):19294. doi:10.1038/s41598-020-76345-2
   PubMed Web of Science ®Google Scholar
• Eminger LA, Hall LD, Hesterman KS, et al. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors. J Am Acad Dermatol. 2015;72(1):21–34; quiz 35–6. doi:10.1016/j.jaad.2014.07.035
   Web of Science ®Google Scholar
• Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood. 2013;122(18):3101–3110. doi:10.1182/blood-2013-05-502203
   PubMed Web of Science ®Google Scholar
• Sundram U. Cutaneous lymphoproliferative disorders: what’s new in the revised 4th edition of the World Health Organization (WHO) classification of lymphoid neoplasms. Adv Anat Pathol. 2019;26(2):93–113. doi:10.1097/PAP.0000000000000208
   PubMed Web of Science ®Google Scholar
• Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):208–213. doi:10.1016/S0190-9622(00)90127-0
   PubMed Web of Science ®Google Scholar
• Chen CC, Chang KC, Medeiros LJ, et al. Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: a spectrum of disease phenotypes associated with ultraviolet irradiation and chronic Epstein-Barr virus infection. Int J Mol Sci. 2020;21(23):9314. doi:10.3390/ijms21239314
   PubMed Web of Science ®Google Scholar
• Cohen JI, Manoli I, Dowdell K, et al. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites. Blood. 2019;133(26):2753–2764. doi:10.1182/blood.2018893750
   PubMed Web of Science ®Google Scholar
• Chen CC, Chang KC, Medeiros LJ, et al. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation. J Cutan Pathol. 2016;43(12):1102–1111. doi:10.1111/cup.12801
   PubMed Web of Science ®Google Scholar
• Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–5032. doi:10.1182/blood-2011-01-293050
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
   PubMed Web of Science ®Google Scholar
• Kim WY, Montes-Mojarro IA, Fend F, et al. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr. 2019;7:71. doi:10.3389/fped.2019.00071
   PubMed Web of Science ®Google Scholar
• Wang X, Wang P, Wang A, et al. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review. BMC Infect Dis. 2021;21(1):17. doi:10.1186/s12879-020-05697-x
   PubMed Web of Science ®Google Scholar
• Guo N, Chen Y, Wang Y, et al. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Diagn Pathol. 2019;14(1):82. doi:10.1186/s13000-019-0859-4
   PubMedGoogle Scholar
• Nahhas AF, Oberlin DM, Braunberger TL, et al. Recent developments in the diagnosis and management of photosensitive disorders. Am J Clin Dermatol. 2018;19(5):707–731. doi:10.1007/s40257-018-0365-6
   PubMed Web of Science ®Google Scholar
• Miyake T, Yamamoto T, Hirai Y, et al. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Br J Dermatol. 2015;172(1):56–63. doi:10.1111/bjd.13411
   PubMed Web of Science ®Google Scholar
• Miyake T, Iwatsuki K, Hirai Y, et al. The AIM of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites. J Med Virol. 2020;92:3689–3696. doi:10.1002/jmv.25811
   PubMed Web of Science ®Google Scholar
• Van Tong H, Brindley PJ, Meyer CG, et al. Parasite infection, carcinogenesis and human malignancy. EBioMedicine. 2017;15:12–23. doi:10.1016/j.ebiom.2016.11.034
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards JE. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32(1):76–102. doi:10.1086/317537
   PubMed Web of Science ®Google Scholar
• Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol. 2006;142(5):587–595. doi:10.1001/archderm.142.5.587
   PubMedGoogle Scholar
• Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673–686. doi:10.1182/blood-2011-10-381921
   PubMed Web of Science ®Google Scholar
• Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83–87.
   PubMedGoogle Scholar
• Magaña M, Massone C, Magaña P, et al. Clinicopathologic features of hydroa vacciniforme-like lymphoma: a series of 9 patients. Am J Dermatopathol. 2016;38(1):20–25. doi:10.1097/DAD.0000000000000385
   PubMed Web of Science ®Google Scholar
• Garzón E, Dávila-Rodríguez JJ. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: a case series. Indian J Dermatol Venereol Leprol. 2021;1–5. doi:10.25259/IJDVL_847_19
   PubMed Web of Science ®Google Scholar
• Xie Y, Wang T, Wang L. Hydroa vacciniforme-like lymphoproliferative disorder: a study of clinicopathology and whole-exome sequencing in Chinese patients. J Dermatol Sci. 2020;99(2):128–134. doi:10.1016/j.jdermsci.2020.06.013
   PubMed Web of Science ®Google Scholar
• Andrea M, Susanna B, Francesca N, et al. The emerging role of type 2 inflammation in asthma. Expert Rev Clin Immunol. 2021;17(1):63–71. doi:10.1080/1744666X.2020.1860755
   PubMed Web of Science ®Google Scholar
• Paik JH, Choe JY, Kim H, et al. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma. 2017;58(1):53–63. doi:10.1080/10428194.2016.1179297
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma C, Wang G, et al. Hydroa vacciniforme-like lymphoproliferative disorder: clinicopathologic study of 41 cases. J Am Acad Dermatol. 2019;81(2):534–540. doi:10.1016/j.jaad.2019.01.011
   PubMed Web of Science ®Google Scholar
• Reina-Campos M, Scharping NE, Goldrath AW. CD8(+) T cell metabolism in infection and cancer. Nat Rev Immunol. 2021;21(11):718–738. doi:10.1038/s41577-021-00537-8
   PubMed Web of Science ®Google Scholar
• Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113(17):3931–3937. doi:10.1182/blood-2008-10-185256
   PubMed Web of Science ®Google Scholar
• Vega F, Medeiros LJ. A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes. Hum Pathol. 2020;102:104–116. doi:10.1016/j.humpath.2020.05.006
   PubMed Web of Science ®Google Scholar
• Mai ZM, Lin JH, Ngan RK, et al. Solar ultraviolet radiation and vitamin D deficiency on Epstein-Barr virus reactivation: observational and genetic evidence from a nasopharyngeal carcinoma-endemic population. Open Forum Infect Dis. 2020;7(10):ofaa426. doi:10.1093/ofid/ofaa426
   PubMed Web of Science ®Google Scholar
• Qiu LH, Li YY, Zheng YX, et al. EBV-DNA拷贝数在EBV+淋巴瘤患者中的临床意义[Clinical significance of EBV-DNA copy number in EBV positive lymphoma patients]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021;29(6):1785–1789. Chinese. doi:10.19746/j.cnki.issn.1009-2137.2021.06.016
   PubMedGoogle Scholar
• Berth M, Vanheule G, Depuydt C, et al. Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection. J Clin Virol. 2011;50(2):184–185. doi:10.1016/j.jcv.2010.11.002
   PubMed Web of Science ®Google Scholar
• Budiningsih I, Dachlan YP, Hadi U, et al. Quantitative cytokine level of TNF-α, IFN-γ, IL-10, TGF-β and circulating Epstein-Barr virus DNA load in individuals with acute Malaria due to P. falciparum or P. vivax or double infection in a Malaria endemic region in Indonesia. PLoS One. 2021;16(12):e0261923. doi:10.1371/journal.pone.0261923
   PubMed Web of Science ®Google Scholar
• Pillai V, Tallarico M, Bishop MR, et al. Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents. Br J Haematol. 2016;173(4):573–581. doi:10.1111/bjh.14044
   PubMed Web of Science ®Google Scholar